Get the Stockscreener App
22.44
0.18%
-0.04
After Hours:
22.44
Innoviva Inc stock is traded at $22.44, with a volume of 1.24M.
It is down -0.18% in the last 24 hours and up +15.43% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$22.48
Open:
$22.51
24h Volume:
1.24M
Relative Volume:
1.48
Market Cap:
$1.68B
Revenue:
$384.03M
Net Income/Loss:
$38.65M
P/E Ratio:
72.39
EPS:
0.31
Net Cash Flow:
$196.35M
1W Performance:
+4.03%
1M Performance:
+15.43%
6M Performance:
+11.70%
1Y Performance:
+24.81%
1-Day Range:
$22.33
$23.42
1-Week Range:
$21.26
$23.42
52-Week Range:
$16.52
$23.42
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
22.44 | 1.68B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Innoviva stock hits 52-week high at $22.81 By Investing.com - Investing.com Nigeria
Innoviva's Financial Metrics Show Resilience Amid Long-Term Growth Challenges - Markets Mojo
Innoviva (NASDAQ:INVA) Sets New 52-Week HighShould You Buy? - MarketBeat
Innoviva stock hits 52-week high at $22.81 - Investing.com
Panic Selling: What is the next catalyst for Innoviva IncWeekly Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn
Resistance Check: Is Innoviva Inc affected by consumer sentiment2025 Analyst Calls & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
New York State Common Retirement Fund Decreases Stock Holdings in Innoviva, Inc. $INVA - MarketBeat
Allianz Asset Management GmbH Has $3.59 Million Holdings in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (INVA) Stock Analysis: Exploring A 50% Potential Upside For Investors - DirectorsTalk Interviews
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Innoviva Inc (NASDAQ:INVA) Presents a Compelling Value Investment Case - ChartMill
33,280 Shares in Innoviva, Inc. $INVA Acquired by Y Intercept Hong Kong Ltd - Defense World
Liquidity Mapping Around (INVA) Price Events - Stock Traders Daily
Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - 富途牛牛
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Increases Stock Position in Innoviva, Inc. $INVA - MarketBeat
Hedge Fund Bets: Is Innoviva Inc impacted by rising ratesMarket Activity Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
Hussman Strategic Advisors Inc. Sells 168,000 Shares of Innoviva, Inc. $INVA - MarketBeat
Investing in Innoviva (NASDAQ:INVA) five years ago would have delivered you a 57% gain - Yahoo Finance
Innoviva (NASDAQ:INVA) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Will Innoviva Inc. outperform tech stocksQuarterly Portfolio Summary & Long-Term Growth Plans - mfd.ru
Innoviva, Inc. (INVA): Investor Outlook Highlights 66.5% Potential Upside - DirectorsTalk Interviews
Armata Extends Innoviva Credit, Warrants and Voting Pact - TipRanks
Will Innoviva Inc. benefit from rate cutsTreasury Yields & Risk Managed Investment Strategies - mfd.ru
Downgrade Watch: Will Innoviva Inc outperform tech stocksTrade Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn
Why (INVA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Street Watch: What is the next catalyst for Innoviva IncInflation Watch & Stock Portfolio Risk Control - baoquankhu1.vn
The Truth About Innoviva Inc: Why Everyone Is Suddenly Watching This ‘Boring’ Stock - AD HOC NEWS
Death Cross: Is Innoviva Inc affected by consumer sentiment2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Cantor Fitzgerald Maintains and Raises Price Target for INVA | I - GuruFocus
Innoviva (NASDAQ:INVA) Shares Cross Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Innoviva (NASDAQ:INVA) Shares Cross Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Innoviva, Inc. (INVA) Stock Analysis: Exploring a 67% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Understanding Momentum Shifts in (INVA) - Stock Traders Daily
Innoviva (INVA) price target decreased by 12.36% to 32.90 - MSN
Can Innoviva Inc. stock beat market expectations this quarterStability vs Neutral Overview & support options for steady strides - Улправда
Innoviva, Inc.Common Stock (NQ: INVA - FinancialContent
Volume Recap: Can Innoviva Inc. stock beat market expectations this quarterJuly 2025 Review & Safe Capital Growth Tips - Улправда
Is Innoviva Inc. stock positioned for digital transformationOil Prices & High Return Trade Guides - Улправда
Is Innoviva Inc. stock in correction or buying zoneJuly 2025 Macro Moves & Weekly Setup with ROI Potential - ulpravda.ru
Los Angeles Daily NewsInnoviva, Inc.Common Stock (Nasdaq:INVA) Detailed Stock Data - FinancialContent
Is Innoviva Inc. (HVE) stock good for wealth creationJuly 2025 Big Picture & Real-Time Buy Zone Alerts - ulpravda.ru
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out - MarketBeat
Nasdaq Futures Spotlight Innoviva’s Royalty-Based Life Sciences Model - Kalkine Media
Innoviva, Inc. (INVA) Stock Report: Exploring A 62% Upside Potential - DirectorsTalk Interviews
Will Innoviva Inc. (HVE) stock recover faster than industry2026 world cup usa national team quarterfinals defensive leaders low block defense knockout prediction preview - ulpravda.ru
Synergy Asset Management LLC Invests $1.85 Million in Innoviva, Inc. $INVA - MarketBeat
INVA Stock Price, Forecast & Analysis | INNOVIVA INC (NASDAQ:INVA) - Chartmill
Avoiding Lag: Real-Time Signals in (INVA) Movement - Stock Traders Daily
Innoviva’s Stock Under the Microscope: Is INVA Quietly Setting Up Its Next Move? - AD HOC NEWS
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):